CUE Earnings

Quarterly EPS
$-5.10
Q3 2024
$-3.83
Q4 2024
$-4.95
Q1 2025
$-2.67
Q2 2025
$-2.10
Q3 2025
$0.17
Q4 2025
$-1.08
Q1 2026
$-24.14
Q2 2026
Latest Revenue7.9M
Latest Net Income-153067000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$24.147.9M-153067000+166.7%-804.1%
Q1 2026-$1.085.7M-5178000+1,250.6%+78.2%
Q4 2025$0.1721.9M1.6M+1,292.3%+104.4%
Q3 2025-$2.102.1M-7448000-35.6%+58.8%
Q2 2025-$2.673.0M-8482000+11.1%+55.5%
Q1 2025-$4.95421.0K-12257000-75.5%+34.0%
Q4 2024-$3.831.6M-9496000-13.5%+55.2%
Q3 2024-$5.103.3M-8660000+58.9%+29.2%
Q2 2024-$6.002.7M-10171000
Q1 2024-$7.501.7M-12347000
Q4 2023-$8.541.8M-13434000
Q3 2023-$7.202.1M-11005000
Cue Biopharma (CUE) — Earnings